ORG-NA7-RIPE
Details
- Name
- ORG-NA7-RIPE
- Type
- Pharma
- Description
- Novartis AG
- MANRS Conformant (MANRS)
- No
- Created
- May 7, 2026, 6:53 a.m.
- Updated
- May 14, 2026, 1:45 p.m.
Autonomous Systems
| ASN | Description | Organization | Country | Announced | RoVista Rank | ROV Ratio | Cone Size |
|---|---|---|---|---|---|---|---|
| 25031 | NOVARTIS-CH | ORG-NA7-RIPE | — | ✔ | — | — | — |
Prefixes
| Prefix | Name | Description | ASNs | Organization | Country | Announced | Monitored | RPKI | Visibility |
|---|---|---|---|---|---|---|---|---|---|
| 160.61.168.0/23 | CH-NOVARTIS-19931203 | Novartis AG | AS25031 | ORG-NA7-RIPE | CH |
✔ | ✘ | Valid | 89.9225% |
| 160.61.170.0/23 | CH-NOVARTIS-19931203 | Novartis AG | AS25031 | ORG-NA7-RIPE | CH |
✔ | ✘ | Valid | 89.9225% |
| 160.61.208.0/24 | CH-NOVARTIS-19931203 | Novartis AG | AS25031 | ORG-NA7-RIPE | CH |
✔ | ✘ | Valid | 89.9225% |
| 160.61.211.0/24 | CH-NOVARTIS-19931203 | Novartis AG | AS25031 | ORG-NA7-RIPE | CH |
✔ | ✘ | Valid | 89.9225% |
| 160.62.1.0/24 | CH-NOVARTIS-20150306 | Novartis AG | AS25031 | ORG-NA7-RIPE | CH |
✔ | ✘ | Valid | 89.9225% |
| 160.62.2.0/24 | CH-NOVARTIS-20150306 | Novartis AG | AS25031 | ORG-NA7-RIPE | CH |
✔ | ✘ | Valid | 89.9225% |
| 160.62.3.0/24 | CH-NOVARTIS-20150306 | Novartis AG | AS25031 | ORG-NA7-RIPE | CH |
✔ | ✘ | Valid | 89.9225% |
| 160.62.4.0/24 | CH-NOVARTIS-20150306 | Novartis AG | AS25031 | ORG-NA7-RIPE | CH |
✔ | ✘ | Valid | 89.9225% |
| 160.62.5.0/24 | CH-NOVARTIS-20150306 | Novartis AG | AS25031 | ORG-NA7-RIPE | CH |
✔ | ✘ | Valid | 89.9225% |
| 160.62.6.0/24 | CH-NOVARTIS-20150306 | Novartis AG | AS25031 | ORG-NA7-RIPE | CH |
✔ | ✘ | Valid | 89.9225% |
| 160.62.7.0/24 | CH-NOVARTIS-20150306 | Novartis AG | AS25031 | ORG-NA7-RIPE | CH |
✔ | ✘ | Valid | 89.9225% |
CH